Literature DB >> 25055183

Pharmacological evidence of α2-adrenergic receptors in the hypotensive effect of Platonia insignis mart.

Marcelo Bezerra Mendes1, José Couras da Silva-Filho, Carla Kelly Barroso Sabino, Daniel Dias Rufino Arcanjo, Cleyton Marcos Melo Sousa, Isabella Cristhina Gonçalves Costa, Mariana Helena Chaves, Rita de Cássia Meneses Oliveira, Aldeídia P Oliveira.   

Abstract

Platonia insignis Mart. (Clusiaceae) is a medicinal plant from the Brazilian Amazon region. The present study evaluated the biological potential of the ethanol extract (Pi-EtOH) and ethyl acetate fraction (Pi-EtOAc) of the P. insignis fruit shells on the cardiovascular system of rats. Pi-EtOH or Pi-EtOAc (12.5, 25, and 50 mg/kg) was administered intravenously in normotensive rats (260-300 g), and the mean arterial pressure and the heart rate were monitored. The Pi-EtOH induced hypotension (-11.56±0.89, -7.43±0.85, and -17.56±1.97 mmHg) followed by bradycardia in two highest doses (-8.89±3.62 and -15.79±1.83 beats/min) and Pi-EtOAc, at the same doses, induced hypotension (-11.2±1.03, -14.48±1.13, -29.89±2.67 mmHg) more intensively, followed by tachycardia at the dose 12.5 and 25 mg/kg (15.64±2.06, 19.31±1.92 beats/min) and bradycardia at a dose of 50 mg/kg (-9.98±7.33 beats/min). The hypotensive response from Pi-EtOAc was not attenuated when used in the pretreatment with L-NAME, verapamil, propranolol, and hexamethonium. However, when using yohimbine, the hypotensive effect was inhibited (-4.42±1.28 (P<.05), -3.29±0.99 (P<.05), 2.06±1.18 mmHg (P<.05); Student's t-test). Hence, the Pi-EtOAc seems to act similarly to the α2-adrenergic agonist in this hypotensive effect.

Entities:  

Keywords:  Platonia insignis; blood pressure; cardiovascular; hypotension; yohimbine

Mesh:

Substances:

Year:  2014        PMID: 25055183      PMCID: PMC4186803          DOI: 10.1089/jmf.2013.0151

Source DB:  PubMed          Journal:  J Med Food        ISSN: 1096-620X            Impact factor:   2.786


  22 in total

Review 1.  Alpha1-adrenergic receptors: new insights and directions.

Authors:  M T Piascik; D M Perez
Journal:  J Pharmacol Exp Ther       Date:  2001-08       Impact factor: 4.030

2.  Pharmacokinetics of the enantiomers of verapamil after intravenous and oral administration of racemic verapamil in a rat model.

Authors:  M M Bhatti; R T Foster
Journal:  Biopharm Drug Dispos       Date:  1997-07       Impact factor: 1.627

3.  Chlorella pyrenoidosa ameliorated L-NAME-induced hypertension and cardiorenal remodeling in rats.

Authors:  Su-Ching Yang; Hsin-Yi Yang; Yi-Ching Yang; Hsiang-Chi Peng; Pei-Yin Ho
Journal:  Eur J Nutr       Date:  2012-05-03       Impact factor: 5.614

4.  Mechanisms underlying the cardiovascular responses to peripheral administration of NPFF in the rat.

Authors:  M Allard; S Labrouche; A Nosjean; R Laguzzi
Journal:  J Pharmacol Exp Ther       Date:  1995-07       Impact factor: 4.030

Review 5.  Alpha 2-adrenergic agonists in cardiovascular anesthesia.

Authors:  J W Flacke
Journal:  J Cardiothorac Vasc Anesth       Date:  1992-06       Impact factor: 2.628

6.  The in vivo cardiovascular effects of box jellyfish Chironex fleckeri venom in rats: efficacy of pre-treatment with antivenom, verapamil and magnesium sulphate.

Authors:  Sharmaine Ramasamy; Geoffrey K Isbister; Jamie E Seymour; Wayne C Hodgson
Journal:  Toxicon       Date:  2004-05       Impact factor: 3.033

Review 7.  Calcium antagonists and vasodilatation.

Authors:  T Godfraind
Journal:  Pharmacol Ther       Date:  1994-10       Impact factor: 12.310

8.  Effects of intracoronary propranolol on coronary blood flow and regional myocardial function in dogs.

Authors:  K Noguchi; R Sunagawa; T Kato; F Nagamine; M Sakanashi
Journal:  Eur J Pharmacol       Date:  1987-12-01       Impact factor: 4.432

9.  Nitro-L-arginine analogues. Dose- and time-related nitric oxide synthase inhibition in brain.

Authors:  R J Traystman; L E Moore; M A Helfaer; S Davis; K Banasiak; M Williams; P D Hurn
Journal:  Stroke       Date:  1995-05       Impact factor: 7.914

10.  Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias.

Authors:  S MacMahon; R Peto; J Cutler; R Collins; P Sorlie; J Neaton; R Abbott; J Godwin; A Dyer; J Stamler
Journal:  Lancet       Date:  1990-03-31       Impact factor: 79.321

View more
  1 in total

1.  Fentanyl vs fentanyl-dexmedetomidine in lumbar foraminotomy surgery.

Authors:  Bushra Abdul Hadi; Saleh M Sbeitan; Ashok K Shakya
Journal:  Ther Clin Risk Manag       Date:  2019-07-15       Impact factor: 2.423

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.